American Association of Clinical Endocrinologists medical guidelines for clinical practice for the prevention and treatment of postmenopausal osteoporosis: 2001 edition, with selected updates for 2003

Endocr Pract. Nov-Dec 2003;9(6):544-64. doi: 10.4158/EP.9.6.544.
No abstract available

Publication types

  • Guideline
  • Practice Guideline
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Accidental Falls / prevention & control
  • Aged
  • Bone Density
  • Bone Development
  • Bone Remodeling
  • Bone and Bones / injuries
  • Calcitonin / administration & dosage
  • Calcitonin / adverse effects
  • Calcium, Dietary / administration & dosage
  • Contraindications
  • Dietary Supplements
  • Diphosphonates / administration & dosage
  • Diphosphonates / adverse effects
  • Endocrinology*
  • Estrogen Replacement Therapy / adverse effects
  • Exercise
  • Female
  • Fractures, Bone / diagnosis
  • Fractures, Bone / etiology
  • Hip Fractures / etiology
  • Humans
  • Osteoporosis, Postmenopausal / complications
  • Osteoporosis, Postmenopausal / diagnosis
  • Osteoporosis, Postmenopausal / prevention & control*
  • Osteoporosis, Postmenopausal / therapy*
  • Selective Estrogen Receptor Modulators / administration & dosage
  • Selective Estrogen Receptor Modulators / adverse effects
  • Teriparatide / administration & dosage
  • Teriparatide / adverse effects
  • Vitamin D / administration & dosage

Substances

  • Calcium, Dietary
  • Diphosphonates
  • Selective Estrogen Receptor Modulators
  • Teriparatide
  • Vitamin D
  • Calcitonin